Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria.
Chinnery
P F
PF
Cartlidge
N E
NE
Burn
D J
DJ
Cleland
P G
PG
McKeith
I
I
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000150:complications* / Q000523:psychology / Q000628:therapy; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000150:complications* / Q000188:drug therapy*; D010479:Pergolide / Q000008:administration & dosage / Q000627:therapeutic use*; D017118:Porphyria, Acute Intermittent / Q000150:complications* / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000150:complications* / Q000523:psychology / Q000628:therapy
D000978:Antiparkinson Agents; D010479:Pergolide